Autoimmune thrombocytopenia (aHIT) is a severe subtype of heparin-induced
thrombocytopenia (HIT) with atypical clinical features caused by highly pathological IgG …

Abstract Heparin Induced Thrombocytopenia (HIT) is caused by antibodies that recognize
platelet factor 4 (PF4) associated with polyanionic glycosaminoglycan drugs or displayed on …

INTRODUCTION Heparin-induced thrombocytopenia (HIT) is a distinct clinicopathologic
syndrome caused by platelet-activating antibodies that recognize complexes of platelet …

Taking stock of advances in clinical recognition, laboratory testing, and pharmacologic
therapy as well as basic aspects of pathogenesis, the Third Edition of Heparin-Induced …

The serotonin release assay (SRA) tests for antibodies responsible for heparin-induced
thrombocytopenia (HIT). By definition, SRA-positive antibodies cause platelet serotonin …

Heparin-induced thrombocytopenia (HIT) is a distinct clinicopathologic syndrome caused by
platelet-activating antibodies that recognize complexes of platelet factor 4-heparin (PF4/H) …

Heparin-induced thrombocytopenia (HIT) is a clinicopathologic condition and adverse drug
reaction caused by immunoglobulin G (IgG) antibodies directed against the heparin-platelet …

An immune-mediated, severe, acquired prothrombotic disorder, heparin-induced
thrombocytopenia type II (HIT II) occurs in 0.5-5% of patients exposed to unfractionated …

Heparin-induced thrombocytopenia (HIT type II) is a potentially serious adverse drug effect.
Unlike other drug-induced thrombocytopenias which cause bleeding, HIT type II causes …

The article describes the case of a patient diagnosed with delayed-onset heparin-induced
thrombocytopenia (HIT) complicated by venous and arterial thromboses. It discusses the …